Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05266703
Other study ID # PILLAR
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 18, 2022
Est. completion date June 30, 2023

Study information

Verified date January 2024
Source Swiss Federal Institute of Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The serum or plasma ferritin concentration (referred to hereafter as ferritin) is the most widely used indicator to detect iron deficiency and a low ferritin indicates depleted iron stores. However, the threshold ferritin that defines iron deficiency remains unclear and diagnostic ferritin cutoffs from expert groups vary widely. Our study aim is to define the ferritin in Kenyan young women at which the body senses iron depletion and begins to upregulate iron absorption from the diet; this approach could provide a functionally defined threshold of iron deficiency in Sub-Saharan African women.


Recruitment information / eligibility

Status Completed
Enrollment 1000
Est. completion date June 30, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 28 Years
Eligibility Inclusion Criteria: - Age 18-28 y, not pregnant or lactating - Body weight <75 kg - body mass index (BMI) between 17 and 25 kg/m2 - No acute illness/infection (self-reported) - No metabolic or gastrointestinal disorders (self-reported) - No use of medications affecting iron absorption or metabolism during the study - No intake of mineral/vitamin supplements 2 weeks prior to the first study visit and during the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Isotopically labelled iron sulfate 15mg
test drink: water containing isotopic iron solution with vitamin C

Locations

Country Name City State
Kenya Msambweni County Referral Hospital Msambweni

Sponsors (2)

Lead Sponsor Collaborator
Swiss Federal Institute of Technology Jomo Kenyatta University of Agriculture and Technology

Country where clinical trial is conducted

Kenya, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fractional iron absorption shift in iron isotopic ratios measured in red blood cells Day 14
Secondary Plasma Ferritin Day 0
Secondary Plasma Ferritin 4 months after isotope administration
Secondary Plasma Ferritin 8 months after isotope administration
Secondary Plasma Ferritin 12 months after isotope administration
Secondary soluble transferrin receptor Day 0
Secondary soluble transferrin receptor 4 months after isotope administration
Secondary soluble transferrin receptor 8 months after isotope administration
Secondary soluble transferrin receptor 12 months after isotope administration
Secondary C-reactive protein Day 0
Secondary C-reactive protein 4 months after isotope administration
Secondary C-reactive protein 8 months after isotope administration
Secondary C-reactive protein 12 months after isotope administration
Secondary alpha-1-glycoprotein Day 0
Secondary alpha-1-glycoprotein 4 months after isotope administration
Secondary alpha-1-glycoprotein 8 months after isotope administration
Secondary alpha-1-glycoprotein 12 months after isotope administration
Secondary Hemoglobin Day 0
Secondary Hemoglobin 4 months after isotope administration
Secondary Hemoglobin 8 months after isotope administration
Secondary Hemoglobin 12 months after isotope administration
Secondary Plasma Hepcidin Day 0
Secondary Isotopic composition of red blood cells shift in iron isotopic ratios measured in red blood cells 4 months after isotope administration
Secondary Isotopic composition of red blood cells shift in iron isotopic ratios measured in red blood cells 8 months after isotope administration
Secondary Isotopic composition of red blood cells shift in iron isotopic ratios measured in red blood cells 12 months after isotope administration
See also
  Status Clinical Trial Phase
Completed NCT04949165 - Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study N/A
Terminated NCT03218384 - Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency Phase 2
Active, not recruiting NCT03516734 - Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh N/A
Completed NCT03572010 - Stable Iron Isotope Method in HIV+ and HIV- Children N/A
Active, not recruiting NCT03703726 - Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures. N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Not yet recruiting NCT05395468 - Diagnosis of Iron Deficiency by Artificial Intelligence Analysis of Eye Photography.
Withdrawn NCT03800446 - Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood N/A
Not yet recruiting NCT03353662 - Sub Regional Micronutrient Survey in Ethiopia
Completed NCT03819530 - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study N/A
Recruiting NCT04144790 - Impact of Iron Supplementation Treatment on Brain Iron Concentrations
Completed NCT03957057 - Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia Phase 3
Completed NCT03642223 - Central and Peripheral Adiposity and Iron Absorption N/A
Not yet recruiting NCT05407987 - Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) Phase 3
Withdrawn NCT03873584 - Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Enrolling by invitation NCT03897673 - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas N/A
Completed NCT04359368 - Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
Active, not recruiting NCT04778072 - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects N/A
Enrolling by invitation NCT05750940 - Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency
Recruiting NCT05126901 - Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years Phase 3